Pure Global

Anti-A1 Lectin - India CDSCO Medical Device Registration

Anti-A1 Lectin is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2021/000021_b5a3bdbceb0b3224f6a3ceeef48b61d8_a409c76f4e58b0bc28395be38bf113a5. This device is marketed under the brand name RPR. The license holder is TULIP DIAGNOSTICS PRIVATE LIMITED, and it is classified as Device Class Class D. The approving authority is Sub Zonal Goa.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class D
Anti-A1 Lectin
UID: MFG/IVD/2021/000021_b5a3bdbceb0b3224f6a3ceeef48b61d8_a409c76f4e58b0bc28395be38bf113a5

Brand Name

RPR

Device Class

Class D

Approving Authority

Sub Zonal Goa

Product Information

Erybank Anti-A1 Lectin is a ready to use purified extract of Dolichos biflorus seeds to differentiate A1 red cells from A2 red cells

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing